28 Jun Mission Bio
Yan Zhang, Ph.D., CEO
April 21 | 2:45pm | Gaudi 2 Ballroom
San Francisco, CA
Mission Bio provides single-cell multi-omics capabilities on their Tapestri Platform, empowering high-impact research and the development of better treatment regimes. The Tapestri Platform enables accurate characterization of cell and gene therapy candidates for safer and more effective therapeutic strategies. We partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical efforts.